Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-106355·ARK Investment Management LLC
Schedule 13G ownership disclosure
CRISPR Therapeutics AG
Common Stock · CUSIP: H17182108
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- ARK Investment Management LLC
Shares: 9,786,973.00 · Class: 10.76%
- Catherine D. Wood
Shares: 9,786,973.00 · Class: 10.76%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-106355
- Form type
- SCHEDULE 13G/A
- Filer
- ARK Investment Management LLC
- CIK
- CIK 1697748
- Filed
- Nov 04, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership